التفاصيل البيبلوغرافية
| العنوان: |
Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura. |
| المؤلفون: |
Chanut, Mathilde, Jaidi, Rym, Kohn, Milena, Grange, Thomas, Brones, Clara, Lombion, Naëlle, Rousselot, Philippe, Longval, Thomas |
| المصدر: |
Platelets; 2022, Vol. 33 Issue 4, p652-653, 2p |
| مصطلحات موضوعية: |
COVID-19 vaccines, MESSENGER RNA, IDIOPATHIC thrombocytopenic purpura |
| مستخلص: |
In 2021, the world experienced the most extensive vaccination campaign to defeat COVID-19. Many cases of idiopathic thrombocytopenia have been reported following injections of SARS-Cov-2 mRNA vaccine. We present the case of a 73-year-old woman with de novo ITP after a first injection of SARS-Cov-2 mRNA vaccine (Moderna vaccine) who experienced a successful rechallenge of SARS-Cov-2 mRNA vaccine (Pfizer vaccine) a few months later. [ABSTRACT FROM AUTHOR] |
|
Copyright of Platelets is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
